NCT07268781

Brief Summary

People with diabetes often experience abnormal blood fat levels, known as dyslipidemia, which increase the risk of heart disease and stroke. The aim of the study, researchers are exploring a natural and practical solution through a healthy snack in the form of cookies. These cookies are made from Golden Rice, which is rich in beta-carotene as a natural antioxidant, and Piper crocatum (red betel leaf) extract, which contains polyphenols and flavonoids that may help lower cholesterol, reduce inflammation, and protect blood vessels. In this study, patients with diabetes will consume the cookies for 28 days, and their blood fat levels will be measured before and after the intervention. The results will then be compared with those of a control group who receive the Golden rice cookies without piper crocatum extract. This research aims to show that Golden Rice with Piper crocatum extract cookies can reduce bad cholesterol and triglycerides, increase good cholesterol, and serve as a safe, affordable, and acceptable food option to support daily diabetes care. If successful, this approach may offer patients and families a simple way to help prevent complications and improve quality of life, alongside regular treatment and lifestyle changes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

October 20, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 8, 2025

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 8, 2025

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

September 30, 2025

Last Update Submit

December 5, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in total Cholesterol (mg/dL)

    Serum total cholesterol will be measured to assess the effect of Golden Rice cookies enriched with Piper crocatum extract on lipid control in patients with diabetes mellitus.

    Baseline (Day 0) and after 28 days of intervention

  • Change in Low-Density Lipoprotein (LDL) Cholesterol (mg/dL)

    LDL cholesterol levels will be measured to evaluate changes following the 28-day intervention

    Baseline (Day 0) to Day 28

  • Change in High-Density Lipoprotein (HDL) Cholesterol (mg/dL)

    HDL cholesterol levels will be measured to determine improvement in protective lipid fractions.

    Baseline (Day 0) to Day 28

  • Change in Triglycerides (mg/dL)

    Serum triglyceride levels will be measured to assess metabolic lipid response to the intervention.

    Baseline (Day 0) to Day 28

Secondary Outcomes (2)

  • Participant adherence Rate (%)

    Baseline to Day 28

  • Incidence of Adverse Events (Number of Participants)

    Baseline to Day 28

Study Arms (2)

Golden Rice cookies With Piper Crocatum extract

EXPERIMENTAL

Participants will receive Golden Rice cookies enriched with Piper crocatum extract as a daily dietary supplement for 28 consecutive days. The cookies are formulated as a functional food, providing β-carotene from Golden Rice and polyphenols from Piper crocatum, which have antioxidant, anti-inflammatory, and lipid-modulating properties. The intervention aims to improve lipid metabolism by reducing total cholesterol, LDL, and triglycerides while increasing HDL levels in patients with Diabetes Mellitus.

Dietary Supplement: Golden Rice cookies with Piper crocatum Extract

Active Comparator (Control)

ACTIVE COMPARATOR

Participants will receive Golden Rice cookies without Piper crocatum extract, identical in appearance and packaging to the intervention cookies, for 28 consecutive days. This control is designed to maintain participant blinding and to serve as a comparison for evaluating the specific effects of Piper crocatum extract on lipid profile outcomes.

Dietary Supplement: Placebo Cookies (Control)

Interventions

Golden Rice cookies enriched with Piper crocatum extract, formulated as a functional food containing β-carotene and polyphenols with antioxidant, anti-inflammatory, and lipid-modulating properties. Participants will consume the cookies daily for 28 consecutive days in addition to their standard diabetes management. This intervention is designed to improve lipid metabolism and reduce dyslipidemia in patients with Diabetes Mellitus.

Golden Rice cookies With Piper Crocatum extract
Placebo Cookies (Control)DIETARY_SUPPLEMENT

Placebo cookies without Golden Rice or Piper crocatum extract, identical in appearance, taste, and packaging to the intervention cookies. Participants will consume placebo cookies daily for 28 consecutive days along with their standard diabetes management. This placebo is used to maintain participant blinding and provide a valid comparison.

Active Comparator (Control)

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged 18-59 years.
  • Patients diagnosed with Type 2 Diabetes Mellitus based on medical records at Tambu Primary Health Center.
  • Able to read and communicate effectively with healthcare staff.
  • Permanent resident in the Tambu area.
  • Willing to participate in the intervention and follow-up evaluations for the duration of the study.

You may not qualify if:

  • Pregnant or breastfeeding women, or those currently undergoing a pregnancy program.
  • Patients with mental health disorders.
  • Patients with severe comorbidities affecting lipid metabolism, such as chronic kidney disease (CKD), hepatitis, congestive heart failure, stroke, or acute coronary syndrome within the past 3 months.
  • Patients who have consumed herbal supplements or high-dose antioxidants within the last month.
  • Patients with severe gastrointestinal disorders, such as chronic diarrhea.
  • Patients with a history of allergy to any ingredients used in the study intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tambu Primary Health Center (Puskesmas Tambu)

Donggala, Central Sulawesi, 94355, Indonesia

Location

RSUD Anutapura Palu

Palu, Central Sulawesi, 94111, Indonesia

Location

Related Publications (3)

  • Setyawati A, Saleh A, Tahir T, Yusuf S, Syahrul S, Aminuddin A, Raihan M, Jafar N, Hamzah H, Arfian N. Matrix Metalloproteinase-9 Testing of Golden Rice Cookies With Piper Crocatum Active Extract for Preventing Foot Ulcers in Patients With Diabetes: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Feb 29;13:e49940. doi: 10.2196/49940.

    PMID: 38422498BACKGROUND
  • https://jppres.com/jppres/pdf/vol13/jppres25.2499_13.6.1847.pdf

    RESULT
  • Setyawati A, Wahyuningsih MSH, Nugrahaningsih DAA, Effendy C, Fneish F, Fortwengel G. Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts. Saudi J Biol Sci. 2021 Dec;28(12):7257-7268. doi: 10.1016/j.sjbs.2021.08.039. Epub 2021 Aug 19.

Related Links

MeSH Terms

Conditions

Diabetes MellitusDyslipidemias

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesLipid Metabolism Disorders

Study Officials

  • ANDINA SETYAWATI, PhD, S.Kep., Ns., M.Kep.

    Hasanuddin University, Faculty of Nursing

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not be informed about whether they are in the intervention or control group, since both groups will receive packaged cookies that appear identical. Investigators and care providers will know the allocation in order to ensure proper delivery of the intervention, but outcome assessors and laboratory personnel measuring lipid profiles will remain blinded to minimize bias.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study is an interventional clinical trial with a parallel-group design to evaluate the effect of Golden Rice cookies enriched with Piper crocatum extract on lipid profile control in patients with Type 2 Diabetes Mellitus. Participants will be divided into two groups: the intervention group, which will receive Golden Rice cookies containing Piper crocatum extract for 28 consecutive days, and the control group, which will receive standard care (placebo) without the functional food intervention. The study follows a pre-test and post-test control group design, where lipid profile parameters including total cholesterol, LDL, HDL, and triglycerides will be assessed at baseline and after the 28-day intervention period. The allocation is randomized, while masking is not applied due to the nature of the dietary intervention. The primary purpose of this study is treatment, aiming to improve lipid metabolism, reduce dyslipidemia, and prevent cardiovascular complications in patients with
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
S.Kep.,Ns

Study Record Dates

First Submitted

September 30, 2025

First Posted

December 8, 2025

Study Start

October 20, 2025

Primary Completion

November 30, 2025

Study Completion

December 31, 2025

Last Updated

December 8, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data (IPD) for this study.

Locations